UCP2 and prediabetes syndrome: Longitudinal studies tracking UCP2 levels during progression from prediabetes to overt diabetes are lacking, making it impossible to determine whether UCP2 upregulation is a primary driver of β-cell failure or a compensatory (albeit insufficient) antioxidant response to chronic oxidative stress [78,86].